Immune Boost Capital

Immune Boost Capital is a philanthropic venture fund based in Irvine, California, focused on advancing therapeutics and technologies across the broad spectrum of immune-mediated diseases, including autoimmune and inflammatory conditions.

We bridge the gap between early-stage scientific innovation and venture-ready investment, providing strategic support to founders and investigators. Our mission is to accelerate the path from bench to bedside, enabling promising autoimmune discoveries to reach the patients who need them most.

As a subsidiary of the Arthritis National Research Foundation, Immune Boost Capital operates with a unique evergreen model, recycling 100% of returns to fuel the next generation of research. We partner with a diverse team of scientists, investors, and healthcare leaders, committed to translating breakthrough science into meaningful patient outcomes. Autoimmune Diagnostics and Therapeutics are our primary focus, with investments spanning the full spectrum of autoimmune conditions.Impact Investing is at the core of our strategy, driving both scientific and social impact.Venture Capital is our investment approach, supporting early-stage companies.Biotech and Life Sciences are key sectors we target.